- Home
- CLOV vs LKFT Comparison
CLOV vs LKFT Comparison
Compare CLOV & LKFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLOV | LKFT |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Belgium |
| Employees | N/A | 452 |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CLOV | LKFT |
|---|---|---|
| Price | $4.55 | $29.84 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.90 | N/A |
| AVG Volume (30 Days) | ★ 6.9M | 134.6K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.03 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $1,924,308,000.00 | N/A |
| Revenue This Year | $52.59 | N/A |
| Revenue Next Year | $15.37 | N/A |
| P/E Ratio | $88.70 | ★ N/A |
| Revenue Growth | ★ 40.34 | N/A |
| 52 Week Low | $1.58 | $28.00 |
| 52 Week High | $5.59 | $30.91 |
Technical Indicators
Market Signals| Indicator | CLOV | LKFT |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 59.93 |
| Support Level | $1.96 | $29.36 |
| Resistance Level | $5.18 | $30.91 |
| Average True Range (ATR) | 0.29 | 0.50 |
| MACD | -0.12 | -0.07 |
| Stochastic Oscillator | 24.80 | 40.23 |
Price Performance
Historical ComparisonAbout CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About LKFT Lakefront Biotherapeutics American Depositary Shares
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.